An in-vitro model of anesthetic hypertonic hyperpyrexia, halothane--caffeine-induced muscle contractures: prevention of contracture by procainamide.
D000769:Anesthesia, Inhalation / Q000009:adverse effects*; D000818:Animals; D001001:Anura; D002110:Caffeine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D046508:Culture Techniques; D004357:Drug Synergism; D005334:Fever / Q000139:chemically induced*; D006221:Halothane / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects*; D011342:Procainamide / Q000494:pharmacology* / Q000627:therapeutic use; D011894:Rana pipiens; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
D002110:Caffeine; D008012:Lidocaine; D011342:Procainamide; D006221:Halothane